Cervical Cancer Prediction Test
Test created by UCL and Innsbruck University also detects DNA markers for breast, womb, and ovarian cancer.
A more precise test for cell changes that can result in cervical cancer has been created by scientists. In the future, the ground-breaking test may be used as a predictive tool for breast, womb, cervical, and ovarian cancer because it can detect DNA markers for other common cancers.
The test’s creators had previously demonstrated that they might be able to detect ovarian and breast cancer or estimate the likelihood that they will manifest by using cervical cells from a standard smear test.
The expert team has now revealed that the new test outperforms existing techniques for identifying women with advanced cell changes who need treatment when tested for cervical cancer.
The test identified 55% of those who would experience cell changes within the following four years in those who did not yet have cell changes but who carried the human papillomavirus (HPV), which is the primary cause of cervical cancer.
The journal Genome Medicine published the findings.
